 |
Knox Lane has made a strategic investment in Spectrum Science, which ranks No. 4 on O’Dwyer’s roster of healthcare firms with fee income of $48.9M in 2021.
Focused on the pharma, biotech and life science categories, Spectrum has handled clients such as AbbVie, Moderna, Horizon Therapies, Takeda Neuroscience and Regeneron.
Shamik Patel, Knox Lane partner, and Brent Gunderson, principal, said Spectrum delivers game-changing solutions across commercialization, including strategic communications, advertising, clinical trial recruitment, scientific strategy and medical communications.
Jonathan Wilson, Spectrum owner/CEO, said the firm has “built a team, structure and culture that puts people at the center from the clients we serve, to the patients they help, to the colleagues we collaborate with around the world.”
Spectrum has more than 300 staffers in the US and UK.
Fahlgren Mortine, No. 19 in O’Dwyer’s rankings of PR firms with 2023 fee income of $39.2M, is being acquired by its Columbus, OH neighbor, The Shipyard, a fast-growing ad agency.
Supreme Group, a healthcare commercialization platform, has acquired Health+Commerce, a strategic PR and marketing shop based in Eagle (ID), serving the medtech and biotech sectors.
Signal Group CEO Blake Androff has purchased the Washington-based public affairs shop from Wiley Rein law firm, which had been its owner since 2014.
Ruder Finn has acquired Flightpath, a 30-year-old New York-based digital marketing shop with 25 staffers.
Have a comment? Send it to 
No comments have been submitted for this story yet.